An official website of the United States government
Home
Name
FCT
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for FCT
Name
Alternate Names
2-FLAMP
2-Fluoro-ARA AMP
2-Fluoro-ara-AMP
Fludara
Fludarabine Monophosphate
Fludarabine Phosphate
Abbreviations
2-FAMP
Category
Chemotherapy
Subcategory
Antimetabolite
NSC Number
312887
Primary Site
Histology
None
Remarks
Coding
This drug should be coded
Name
Alternate Names
11C topotecan
Hycamtin
SKF-104864
Topotecan Hydrochloride
Abbreviations
SKFS
Category
Chemotherapy
Subcategory
Topoisomerase inhibitor
NSC Number
609699
Primary Site
Histology
None
Remarks
Phase II (colorectal, NSCLC) Phase II/III SCLC Phase III MDS, ovarian Topoisomerase I inhibitor. FDA approved use on small cell lung cancer and ovarian cancer. GlaxoSmithKline.
Coding
This drug should be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Breast
leukemia
lymphoma
multiple myeloma
neuroblastoma
ovarian cancer
retinoblastoma
soft tissue sarcoma
Wilm's tumor
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded
